Cargando…
Immune checkpoint regulator PD-L1 expression on tumor cells by contacting CD11b positive bone marrow derived stromal cells
BACKGROUND: Expression of programmed cell death ligand 1 (PD-L1) is an important process by which tumor cells suppress antitumor immunity in the tumor microenvironment. Bone marrow (BM)–derived immune cells are an important component of the tumor microenvironment. However, the link between PD-L1 ind...
Autores principales: | Noh, Hyangsoon, Hu, Jiemiao, Wang, Xiaohong, Xia, Xueqing, Satelli, Arun, Li, Shulin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4353689/ https://www.ncbi.nlm.nih.gov/pubmed/25889536 http://dx.doi.org/10.1186/s12964-015-0093-y |
Ejemplares similares
-
Potential Function of Exogenous Vimentin on the Activation of Wnt Signaling Pathway in Cancer Cells
por: Satelli, Arun, et al.
Publicado: (2016) -
EMT circulating tumor cells detected by cell-surface vimentin are associated with prostate cancer progression
por: Satelli, Arun, et al.
Publicado: (2017) -
Induction of NKG2D ligand expression on tumor cells by CD8(+) T cell engagement-mediated activation of nuclear factor-kappa B and p300/CBP-associated factor
por: Hu, Jiemiao, et al.
Publicado: (2019) -
CD8(+)T cell–specific induction of NKG2D receptor by doxorubicin plus interleukin-12 and its contribution to CD8(+)T cell accumulation in tumors
por: Hu, Jiemiao, et al.
Publicado: (2014) -
WSX1 act as a tumor suppressor in hepatocellular carcinoma by downregulating neoplastic PD-L1 expression
por: Wu, Man, et al.
Publicado: (2021)